✦ LIBER ✦

Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study)

✍ Scribed by Agustí Barnadas; Ricard Mesía; Margarita Majem; Ramón Galiana; Antonio López-Pousa; José M. de Vega; Mireia Margelí; Vicente Valentí; Lluís Anglada; Ariadna Lloansí; Antonio Arellano

Book ID: 107597787
Publisher: Springer Milan
Year: 2011
Tongue: Spanish
Weight: 182 KB
Volume: 13
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-011-0650-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neurotoxicity in a phase I trial of cont

Neurotoxicity in a phase I trial of continuous-infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer

✍ Gerald H. Clamon; Lynn Baatz; Henry T. Hoffman; David H. Hussey; Matthew Glascoc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

## Background: Both twice daily fractionated radiotherapy and concurrent cisplatin with once-daily radiotherapy have been shown to improve local disease control in patients with head and neck cancer. the objective of this phase i trial was to determine the maximum tolerated dose of cisplatin which

Phase II study of docetaxel and topoteca

Phase II study of docetaxel and topotecan combination chemotherapy in patients with advanced head and neck cancer

✍ RobertI. Haddad; DavidA. Echo 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 161 KB

Phase I/II study of weekly docetaxel dos

Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer

✍ Nobuyuki Yamamoto; Yasumasa Nishimura; Kazuhiko Nakagawa; Kaoru Matsui; Masahiro 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 258 KB

Prospective phase II trial of cetuximab

Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma

✍ F. Alongi; M. Bignardi; I. Garassino; S. Pentimalli; R. Cavina; P. Mancosu; G. R 📂 Article 📅 2011 🏛 Springer 🌐 German ⚖ 419 KB

A phase II study of neoadjuvant bevacizu

A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer

✍ Giampietro Gasparini; Francesco Torino; Takayuki Ueno; Stefano Cascinu; Teresa T 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 305 KB

Phase I trial and pharmacokinetics of es

Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma

✍ Philip C. Amrein; John R. Clark; Jeffrey G. Supko; Richard L. Fabian; Chiu C. Wa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

## Abstract ## BACKGROUND Amifostine was developed to protect normal tissues from radiation exposure. The current study was undertaken to determine whether amifostine would allow the delivery of greater numbers of weekly paclitaxel treatments with concomitant, hyperfractionated radiotherapy in pat